Document ID: EPA-HQ-OPP-2015-0423-0001
Agency: epa
Document Type: Notice
Title: Federal Insecticide, Fungicide, and Rodenticide Act Scientific Advisory Panel; Nominations
Posted Date: 2015-08-12T04:00Z

[Federal Register Volume 80, Number 155 (Wednesday, August 12, 2015)]
[Notices]
[Pages 48306-48315]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-19828]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2015-0423; FRL-9929-66]

Nominations to the FIFRA Scientific Advisory Panel; Request for 
Comments

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice provides the names, addresses, professional 
affiliations, and selected biographical data of persons recently 
nominated to serve on the Scientific Advisory Panel (SAP) established 
under section 25(d) of the Federal Insecticide, Fungicide, and 
Rodenticide Act (FIFRA). The Panel was created on November 28, 1975, 
and made a statutory Panel by amendment to FIFRA, dated October 25, 
1988. The Agency, at this time, anticipates selecting two new members 
to serve on the panel as a result of membership terms that will expire 
in 2015. Public comments on the current nominations are invited, as 
these comments will be used to assist the Agency in selecting the new 
chartered Panel members.

DATES: Comments, identified by docket ID number EPA-HQ-OPP-2015-0423, 
must be received on or before August 27, 2015.

ADDRESSES: Submit your comments, identified by docket identification 
(ID) number EPA-HQ-OPP-2015-0423, by one of the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the online instructions for submitting comments. Do not submit 
electronically any information you consider to be Confidential Business 
Information (CBI) or other information whose disclosure is restricted 
by statute.
     Mail: OPP Docket, Environmental Protection Agency Docket 
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW., Washington, DC 
20460-0001.

[[Page 48307]]

     Hand Delivery: To make special arrangements for hand 
delivery or delivery of boxed information, please follow the 
instructions at http://www.epa.gov/dockets/contacts.html.

FOR FURTHER INFORMATION CONTACT: Steven M. Knott, DFO, Office of 
Science Coordination and Policy (7201M), Environmental Protection 
Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460-0001; 
telephone number: (202) 564-0103; fax number: (202) 564-8382; email 
address: knott.steven@epa.gov.

SUPPLEMENTARY INFORMATION:

 I. General Information

 A. Does this action apply to me?

    This action is directed to the public in general. This action may, 
however, be of interest to persons who are or may be required to 
conduct testing of chemical substances under the Federal Food, Drug, 
and Cosmetic Act (FFDCA) and FIFRA. Since other entities may also be 
interested, the Agency has not attempted to describe all the specific 
entities that may be affected by this action. If you have any questions 
regarding the applicability of this action to a particular entity, 
consult the DFO listed under FOR FURTHER INFORMATION CONTACT.

B. What should I consider as I prepare my comments for EPA?

    When submitting comments, remember to:
    1. Identify the document by docket ID number and other identifying 
information (subject heading, Federal Register date and page number).
    2. Follow directions. The Agency may ask you to respond to specific 
questions or organize comments by referencing a Code of Federal 
Regulations (CFR) part or section number.
    3. Explain why you agree or disagree; suggest alternatives and 
substitute language for your requested changes.
    4. Describe any assumptions and provide any technical information 
and/or data that you used.
    5. If you estimate potential costs or burdens, explain how you 
arrived at your estimate in sufficient detail to allow for it to be 
reproduced.
    6. Provide specific examples to illustrate your concerns and 
suggest alternatives.
    7. Explain your views as clearly as possible, avoiding the use of 
profanity or personal threats.
    8. Make sure to submit your comments by the comment period deadline 
identified.

II. Background

    The FIFRA SAP serves as the primary scientific peer review 
mechanism of EPA's Office of Chemical Safety and Pollution Prevention 
(OCSPP) and is structured to provide scientific advice, information and 
recommendations to the EPA Administrator on pesticides and pesticide-
related issues as to the impact of regulatory actions on health and the 
environment. Established in 1975 under FIFRA, the FIFRA SAP is a 
Federal advisory committee that operates in accordance with 
requirements of the Federal Advisory Committee Act (FACA). The FIFRA 
SAP is composed of a permanent panel consisting of seven members who 
are appointed by the EPA Administrator from nominees provided by the 
National Institutes of Health (NIH) and the National Science Foundation 
(NSF). FIFRA established a Science Review Board consisting of at least 
60 scientists who are available to the SAP on an ad hoc basis to assist 
in reviews conducted by the FIFRA SAP. As a peer review mechanism, the 
FIFRA SAP provides comments, evaluations and recommendations to improve 
the effectiveness and quality of analyses made by Agency scientists. 
Members of the FIFRA SAP are scientists who have sufficient 
professional qualifications, including training and experience, to 
provide expert advice and recommendations to the Agency.
    In accordance with the statute, the SAP is composed of a permanent 
panel of seven members, selected and appointed by the Deputy 
Administrator of EPA, as designated by the Administrator from nominees 
submitted by both the NSF and the NIH. The Agency, at this time, 
anticipates selecting two new members to serve on the panel as a result 
of membership terms that will expire this year. The Agency requested 
nominations of experts to be selected from the fields of human 
toxicology, environmental toxicology, pathology, risk assessment and/or 
environmental biology with demonstrated experience and expertise in all 
phases of the risk assessment process including: Planning, scoping, and 
problem formulation; analysis; and interpretation and risk 
characterization (including the interpretation and communication of 
uncertainty). Nominees should be well published and current in their 
field of expertise. The statute further stipulates that we publish the 
name, address and professional affiliation in the Federal Register.

III. Charter

    A Charter for the FIFRA Scientific Advisory Panel dated October 17, 
2014 was issued in accordance with the requirements of the Federal 
Advisory Committee Act, Public Law 92-463, 86 Stat. 770 (5 U.S.C. App. 
I).

A. Qualifications of Members

    Members are scientists who have sufficient professional 
qualifications, including training and experience, to provide expert 
comments on the impact of pesticides on health and the environment. No 
persons shall be ineligible to serve on the Panel by reason of their 
membership on any other advisory committee to a Federal department or 
agency or their employment by a Federal department or agency (except 
the EPA). The Deputy Administrator appoints individuals to serve on the 
Panel for staggered terms of 3 years. Panel members are subject to the 
provisions of 40 CFR part 3, subpart F, Standards of Conduct for 
Special Government Employees, which include rules regarding conflicts 
of interest. Each nominee selected by the Deputy Administrator, before 
being formally appointed, is required to submit a confidential 
statement of employment and financial interests, which shall fully 
disclose, among other financial interests, the nominee's sources of 
research support, if any.
    In accordance with section 25(d)(1) of FIFRA, the Deputy 
Administrator shall require all nominees to the Panel to furnish 
information concerning their professional qualifications, educational 
background, employment history, and scientific publications.

B. Applicability of Existing Regulations

    With respect to the requirements of section 25(d) of FIFRA that the 
Administrator promulgate regulations regarding conflicts of interest, 
the Charter provides that EPA's existing regulations applicable to 
Special Government Employees, which include advisory committee members, 
will apply to the members of the Scientific Advisory Panel. These 
regulations appear in 40 CFR part 3, subpart F. In addition, the 
Charter provides for open meetings with opportunities for public 
participation.

C. Process of Obtaining Nominees

    In accordance with the provisions of section 25(d) of FIFRA, EPA, 
on April 21, 2015, requested that the NIH and the NSF nominate 
scientists to fill vacancies occurring on the Panel. The Agency 
requested nominations of experts in the fields of human toxicology, 
environmental toxicology, pathology,

[[Page 48308]]

risk assessment, and/or environmental biology with demonstrated 
experience and expertise in all phases of the risk assessment process 
including: Planning, scoping, and problem formulation; analysis; and 
interpretation and risk characterization (including the interpretation 
and communication of uncertainty). NIH and NSF responded by letter, 
providing the Agency with a total of 34 nominees. Copies of these 
letters, with the listed nominees, are available in the public docket 
referenced in unit I.B.1. of this notice. Of the 34 nominees, 18 are 
interested and available to actively participate in SAP meetings (see 
Section IV. Nominees). One nominee is currently serving as member of 
the FIFRA SAP, and is not listed. In addition to the current nominees 
interested, at EPA's discretion, nominees who were interested and 
available during the previous nomination process in the January 24, 
2014 Federal Register (79 FR 4158) (FRL-9904-66), may also be 
considered. Of the current 34 nominations, the following 15 individuals 
are not available:

    1. Asa Bradman, Ph.D., University of CA, Berkeley, CA.
    2. Mark G. Evans, DVM, Ph.D., ACVP, Pfizer Global Research and 
Development Drug Safety Research and Development, San Diego, CA.
    3. John Groopman, Ph.D., Johns Hopkins University, Baltimore, 
MD.
    4. Stephen S. Hecht, Ph.D., University of Minnesota, 
Minneapolis, MN.
    5. Marie Lyn Miranda, Ph.D., Rice University, Houston, TX.
    6. Frederica P. Perera, Ph.D., MPH, Columbia University, New 
York, NY.
    7. Irva Hertz-Picciotto, Ph.D., University of California, Davis, 
CA.
    8. Thomas A.E. Platts-Mills, M.D., University of Virginia, 
Charlottesville, VA.
    9. Michael Roe, Ph.D., North Carolina State University, Raleigh, 
NC.
    10. Ana Diez Roux, M.D, Ph.D., MPH, Drexel University, 
Philadelphia, PA.
    11. Jonathan M. Samet, MD, University of Southern California, 
Los Angeles, CA.
    12. David Siegel, MD, National Institute of Health, Rockville, 
MD.
    13. Allan H. Smith, MD, Ph.D., University of California, 
Berkeley, CA.
    14. Frank Speizer, SCD, MD, Harvard Medical School, Boston, MA.
    15. Robert Williams, MD, University of New Mexico Health 
Sciences Center, Albuquerque, NM.

IV. Nominees

    Following are the names, addresses, professional affiliations, and 
selected biographical data of current nominees being considered for 
membership on the FIFRA SAP. The Agency anticipates selecting two 
individuals to fill vacancies occurring in 2015.

1. Nicole L. Achee, Ph.D.

    i. Expertise: Epidemiology control of arthropod-borne diseases 
including evaluation of vector ecology, habitat management, and adult 
control strategies, disease risk modeling using GIS and remote sensing 
technologies, and evaluation of chemical actions against mosquito 
vectors under both laboratory and field conditions.
    ii. Education: Ph.D. Medical Entomology, Uniformed Services 
University of the Health Sciences; MSc, Zoology, Texas A&M University; 
BS, Biology, St. Louis University.
    iii. Professional Experience: Dr. Achee is a Medical Entomologist 
(Research Associate Professor) within the Department of Biological 
Sciences and holds a joint Associate Professor appointment in the Eck 
Institute for Global Health at the University of Notre Dame. She joined 
the University of Notre Dame faculty in 2013, following a 2-year 
position as Assistant Professor at the Uniformed Services University of 
the Health Sciences in Bethesda, MD. She has a combined 15 years of 
experience in vector behavior research related to the epidemiology and 
control of arthropod-borne diseases, including evaluation of vector 
ecology, habitat management and adult control strategies, disease risk 
modeling using GIS and remote sensing technologies, and evaluation of 
chemical actions against mosquito vectors under both laboratory and 
field conditions. She has worked in the international settings of 
Belize, Mexico, Peru, Suriname, Indonesia, Nepal, South Korea, 
Thailand, and Tanzania. Dr. Achee was the principal investigator of a 
research program funded by the Bill & Melinda Gates Foundation focused 
on the development of spatial repellents in combination push-pull 
systems to reduce human-vector contact for dengue prevention. She is a 
Working Group member of the World Health Organization (WHO) Pesticide 
Evaluation Scheme (WHOPES), the Chair of the American Committee of 
Medical Entomology (ACME) of the American Society of Tropical Medicine 
and Hygiene (ASTMH), a representative of the WHO Global Collaboration 
for the Development of Pesticides for Public Health partnership 
(GCDPP), Vector Control Working Group member of Roll Back Malaria and 
served as the lead scientist for the recent publication of the WHO 
Guidelines for Efficacy Testing of Spatial Repellents. She is currently 
the lead Principal Investigator of a multicenter intervention trial 
dedicated to generating evidence of the protective efficacy of spatial 
repellents for prevention of malaria and dengue human infections for 
use towards full WHO recommendations. Her latest efforts have been 
dedicated to co-Directing the Belize Vector and Ecology Center (BVEC) 
in Orange Walk Town, Belize to serve as a regional platform of 
excellence for research and education in arthropod-borne diseases.

2. George B. Corcoran, Ph.D., ATS

    i. Expertise: Pharmacological and toxicological adverse cellular 
outcomes, and factors that govern drug and chemical injuries including 
drug metabolism and nutrition.
    ii: Education: Ph.D., Pharmacology, Department of Pharmacology, 
School of Medicine, George Washington University; MS, Chemistry, 
Bucknell University; BA, Chemistry, Ithaca College.
    iii. Professional Experience: Dr. Corcoran is Professor and 
Chairman of the Department of Pharmaceutical Sciences, College of 
Pharmacy & Health Sciences, Wayne State University, and Adjunct 
Professor of Pediatrics, Wayne State University School of Medicine. Dr. 
Corcoran earned his BA in Chemistry (Ithaca College `70), MS in 
Chemistry (Bucknell University `73), and Ph.D. in Pharmacology/
Toxicology (George Washington University `80), before completing 
Postdoctoral Fellow training in Toxicology (Baylor College of Medicine 
and Methodist Hospital `81). Prior to his appointment at Wayne State, 
Dr. Corcoran served as Assistant Professor of Pharmaceutics at the 
State University of New York at Buffalo, followed by Associate 
Professor and later Professor, and Director of the Toxicology Graduate 
Program at the University of New Mexico. Dr. Corcoran has published 
over 200 original research papers, abstracts and other reports, and has 
received nearly $6 million in grants and contracts as Principal 
Investigator, Co-Principal Investigator, and Co-Investigator. He has 
chaired grant review panels for the NIH, the National Academies, and 
the Howard Hughes Medical Institute, and has refereed papers for more 
than 50 national and international scientific journals. He has 
contributed to the training of over 150 MS and Ph.D. graduates, 3200 
pharmacists, and hundreds of undergraduate research students. His 
research interests are multidisciplinary and translational. They focus 
on cellular injury and cell death, and factors that govern drug and 
chemical injuries, including drug metabolism and nutrition. Approaches 
to translate basic discoveries to improve human health involve 
retrospective and prospective clinical investigation of human

[[Page 48309]]

volunteers and patients, integrated in vivo models, cellular and 
molecular biology, pharmacokinetics, and synthetic chemistry. Specific 
areas of investigation include cell death by necrosis and apoptosis, 
the role of DNA damage in acute cell death, drug and chemical injury to 
the liver, nutrition and particularly obesity as overlooked factors in 
drug and chemical injury, drug biotransformation including by CYPs, and 
toxicity of drugs such as acetaminophen (paracetamol). Dr. Corcoran is 
a Fellow of the Academy of Toxicological Sciences, the top US 
credentialing organization for toxicologists. He was elected to its 
Executive Board and appointed to the National Toxicology Program Board 
of Scientific Counselors in 2012. He has been a Delegate to the 
International Congress of Toxicology and member of the International 
Union of Toxicology Developing Countries Committee. He is a former 
Member of the Science Advisory Board of the US Environmental Protection 
Agency, is former Chair of the Executive Board of the Council of 
Scientific Society Presidents, and is a past member of the 
Intergovernmental Scientific Advisory Committee on Alternative 
Toxicological Methods. He has contributed to the scientific direction 
of the American Society for Pharmacology and Experimental Therapeutics 
as a member of its Scientific Council, and served on the Research and 
Graduate Affairs Committee of the American Association of Colleges of 
Pharmacy. Dr. Corcoran is sought as an expert in toxic tort, product 
liability and other legal matters. At the University of New Mexico, Dr. 
Corcoran advised Health Sciences Vice President Jane Henney (FDA 
Commissioner 1998-2000) as a member of her Health Sciences Leadership 
Council. He is Past President of the Society of Toxicology, the largest 
toxicology organization in the world with over 7,000 members from 
academia, industry, government, medicine, law and other fields 
practicing in the USA and over 50 foreign countries. He has contributed 
to Society positions having national and international impact, from the 
best science for evidence-based safety legislation, to organization 
ethics and governance. He serves as Associate Editor of Toxicology and 
Applied Pharmacology [2002-date], Editor of the Journal of 
Pharmaceutical Sciences and Pharmacology [2014-date] and Editor of the 
MO Online Journal of Toxicology [2014-date]. He has been an Editorial 
Board Member of the international journals Pharmacology and Toxicology, 
Basic and Clinical Pharmacology and Toxicology, Toxicology Letters, and 
the Journal of Toxicology and Environmental Health. During his service 
on the National Institutes of Health Alcohol-Toxicology 1 Study 
Section, he evaluated over 1,000 NIH grant applications.

3. Deborah A. Cory-Slechta, Ph.D.

    i. Expertise: Relationship between brain neurotransmitter systems 
and neurodevelopment associated with alteration by exposures to 
environmental toxicants.
    ii: Education: Ph.D., Experimental Psychology, University of 
Minnesota; MA, Experimental Psychology, Western Michigan University; 
BS, Psychology, Western Michigan University.
    iii. Professional Experience: Dr. Deborah Cory-Slechta is a 
Professor in the Department of Environmental Medicine, Pediatrics and 
Public Health Sciences at the University of Rochester School of 
Medicine and Dentistry. Dr. Deborah Cory-Slechta became Chair of its 
Department of Environmental Medicine and Director of the NIEHS 
Environmental Health Sciences Center in 1998, and served as Dean for 
Research from 2000-2002. She then became Director of the Environmental 
and Occupational Health Sciences Institute (EOHSI) and Chair of the 
Department of Environmental and Community Medicine at the UMDNJ-Robert 
Wood Johnson Medical School from 2003-2007, before returning to URMC as 
Professor in Environmental Medicine, Pediatrics and Public Health 
Sciences. Dr. Cory-Slechta has served on national review and advisory 
panels of the National Institutes of Health, the National Institute of 
Environmental Health Sciences, the Food and Drug Administration, the 
National Center for Toxicological Research, the Environmental 
Protection Agency, the National Academy of Sciences, the Institute of 
Medicine, and the Agency for Toxic Substances and Disease Registry, 
Centers for Disease Control. In addition, Dr. Cory-Slechta has served 
on the editorial boards of the journals Neurotoxicology, Toxicology, 
Toxicological Sciences, Fundamental and Applied Toxicology, 
Neurotoxicology and Teratology, and American Journal of Mental 
Retardation. She has held the elected positions of President of the 
Neurotoxicology Specialty Section of the Society of Toxicology, 
President of the Behavioral Toxicology Society, and been named a Fellow 
of the American Psychological Association. Her research has focused 
largely on the relationships between brain neurotransmitter systems and 
neurodevelopment, and how such relationships are altered by exposures 
to environmental toxicants, including the role played by environmental 
neurotoxicant exposures in developmental disabilities and 
neurodegenerative diseases. This work has included the effects of 
developmental exposures to metals, pesticides, and air pollutants as 
well as combined exposures to metals and stress in experimental animal 
models as well as in human cohort studies. These research efforts have 
resulted in over 155 papers and book chapters to date.

4. Victor G. De Gruttola, ScD

    i. Expertise: Development of innovative study designs and 
analytical methods for evaluation of new therapies for HIV-related 
disease.
    ii. Education: ScD, Biostatistics, Harvard School of Public Health; 
SM, Bioengineering, Harvard University; SM, Epidemiology, Harvard 
School of Public Health; BS, Physics, Brown University.
    iii. Professional Experience: Dr. De Gruttola received his ScD in 
1986 from the Biostatistics Department at HSPH--the department for 
which he served as Chair from 2009-2014. His research focuses on 
development of statistical methods required for appropriate public 
health response to the AIDS epidemic both within the US and 
internationally. The aspects of the epidemic on which he has worked 
include transmission of, and natural history of infection with, the 
Human Immunodeficiency Virus (HIV), as well as research on 
antiretroviral treatments, including the development and consequences 
of resistance to treatments. The broad goals of his research include 
developing treatment strategies that provide durable virologic 
suppression while preserving treatment options after failure, and 
evaluating the community-level impact of packages of prevention 
interventions, including antiviral treatment. He served as the Director 
of the Statistics and Data Analysis Center of the Adult Project of the 
AIDS Clinical Trials Group from 1996 to 2003--the period in which 
highly active antiretroviral treatment was developed, and he was 
instrumental in designing and analyzing studies of the best means of 
providing such therapy. He also served from 2011-2015, as co-PI (with 
PI Max Essex) on a community-randomized study of a combination HIV 
prevention strategy in Botswana.

5. David C. Dorman, DVM, Ph.D., DABVT, DABT, ATS

    i. Expertise: Neurotoxicology, and risk assessment.

[[Page 48310]]

    ii: Education: Ph.D., Veterinary Biosciences/Toxicology, University 
of Illinois; DVM Colorado State University; B.A. Chemistry, University 
of San Diego.
    iii. Professional Experience: Dr. Dorman is a professor of 
toxicology in the Department of Molecular Biosciences in the College of 
Veterinary Medicine at North Carolina State University. Dr. Dorman 
received his undergraduate training in chemistry from the University of 
San Diego, his DVM from Colorado State University, and he completed a 
combined Ph.D. and residency program in toxicology at the University of 
Illinois, Urbana-Champaign. He is a diplomat of the American Board of 
Veterinary Toxicology and the American Board of Toxicology. Dr. Dorman 
has chaired or served on numerous NRC committees. His recent NRC 
chairmanships include the Committee on Predictive-Toxicology Approaches 
for Military Assessments of Acute Exposures and the Committee on Design 
and Evaluation of Safer Chemical Substitutions--A Framework to Inform 
Government and Industry Decisions. He has been recently named as chair 
of the NRC's Committee on Toxicology and the Committee on Unraveling 
Low Dose Toxicity: Case Studies of Systematic Review of Evidence. He 
has served on other advisory boards for the US Navy, NASA, and USDA, 
and is currently a member of the National Toxicology Program's Board of 
Scientific Counselors. He is an elected fellow of both the Academy of 
Toxicological Sciences and the American Association for the Advancement 
of Sciences. The primary objective of his research is to provide a 
refined understanding of chemically induced neurotoxicity in laboratory 
animals that will lead to improved assessment of potential 
neurotoxicity in humans. Dr. Dorman's other research interests include 
clinical veterinary toxicology, nasal toxicology, pharmacokinetics, and 
cognition and olfaction in animals. He has over 145 peer-reviewed 
research publications including work with pesticides, metals, hydrogen 
sulfide, and a variety of industrial chemicals.

6. Valery E. Forbes, Ph.D.

    i. Expertise: Population ecology and modeling, fate and effects of 
toxic chemicals in sediments, and ecological risk assessment.
    ii. Education: Ph.D., Coastal Oceanography, State University of New 
York; MSc Marine Environmental Science, State University of New York; 
BA Biology; BA Geology, State University of New York.
    iii. Professional Experience: Dr. Valery E. Forbes is Dean of the 
College of Biological Sciences at University of Minnesota. Dr. Forbes 
was Director of the School of Biological Sciences at the University of 
Nebraska-Lincoln from 2011-2015. From 1989-2010, she lived and worked 
in Denmark, most recently as the Founding Chair of the Department of 
Environmental, Social and Spatial Change and Professor of Aquatic 
Ecology and Ecotoxicology at Roskilde University. Dr. Forbes received 
her Bachelor's Degree (Biology & Geology) from the State University of 
New York at Binghamton in 1983, a MSc (Marine Environmental Science) 
from SUNY-Stony Brook in 1984, and a Ph.D. (Coastal Oceanography), also 
from SUNY- Stony Brook in 1988. Specific research topics include 
population ecology and modeling, fate and effects of toxic chemicals in 
sediments, and ecological risk assessment. Dr. Forbes has graduated 
approximately 50 MSc and Ph.D. students over her career and established 
a Danish Graduate School in Environmental Stress Studies (GESS) based 
at Roskilde University. While based in Europe, Dr. Forbes served as 
work package leader on two major EU 7th Framework Projects: CREAM (a 
Marie Curie Initial Training Network on Mechanistic Effect Models for 
Ecological Risk Assessment of Chemicals) and NanoReTox (a multi- 
institution research project on The Reactivity and Toxicity of 
Engineered Nanoparticles: Risks to the Environment and Human Health). 
More recently, she has received funding from the National Institute of 
Mathematical and Biological Synthesis (NIMBioS) for multi-partite 
initiatives to develop predictive models for the ecological risk 
assessment of chemicals. Dr. Forbes has published well over 100 
internationally peer-reviewed articles and two books on these topics. 
She has served on the Danish Natural Sciences Research Council, the 
European Research Council and as ad hoc reviewer for numerous funding 
agencies from various countries. She is on the editorial board of 
several international journals and provides scientific advice to the 
private and public sectors.

7. John Grieco, Ph.D.

    i. Expertise: Epidemiology, ecology, and transmission dynamics of 
vector-borne illness.
    ii. Education: Ph.D., Medical Zoology, Uniformed Services 
University; MS Medical Entomology, Texas A&M University; BS, Biology, 
University of Notre Dame.
    iii. Professional Experience: Dr. John Grieco is a Research 
Associate Professor of Medical Entomology and Associate Director of the 
Eck Institute of Global Health at the University of Notre Dame in Notre 
Dame, Indiana. Dr. Grieco's work is multidisciplinary with a focus on 
the biology, ecology and transmission dynamics of vector-borne illness. 
He has a long history of working on vector borne disease throughout the 
tropics and his research centers on malaria, Japanese Encephalitis, 
Dengue, Chagas, and rickettsial pathogens. Dr. Grieco has an extensive 
history in the design of novel repellents, irritants and toxicants for 
disease vectors. He has developed a number of field and laboratory 
assays for identifying and optimizing behavior modifying compounds for 
use in the control of mosquito, sandfly, and triatome vectors. Dr. 
Grieco serves as an external advisor to the Bill and Melinda Gates 
Foundation, the World Health Organization (WHO), the US Centers for 
Disease Control and the US Department of Defense in the area of Spatial 
Repellents and their advancement to recommendation. Dr. Grieco has co-
authored the WHO guidelines for the evaluation of spatial repellents 
and he currently holds two patents for novel repellent compounds.

8. Byron Jones, Ph.D.

    i. Expertise: Toxicogenetics, neurobehavioral, and developmental 
toxicology.
    ii. Education: BA, Psychology, Eastern Washington University; MA, 
Psychology, University of Arizona; Ph.D. Physiological and Comparative 
Psychology, Psychopharmacology, University of Arizona.
    iii. Professional Experience: Dr. Byron Jones is professor of 
Genetics, Genomics, and Informatics at the University of Tennessee 
Health Sciences Center, Memphis. Dr. Jones received his Ph.D. training 
in the Departments of Psychology and Pharmacology and Toxicology at the 
University of Arizona. He received postdoctoral training in 
neuropharmacology at the University of Arizona and in pharmacogenetics 
at the University of Colorado. In 1991, he was a founding member of the 
Department of Biobehavioral Health at The Pennsylvania State University 
and developed a program in pharmacogenetics and toxicogenetics at that 
institution. He has trained 10 Ph.D. and 8 MS students and supervised 
numerous undergraduate honors theses at PSU. In 1998-1999, he was 
awarded a Poste Orange senior visiting research position at Institute 
Fran[ccedil]ois Magendie, Bordeaux, France to study the genetics of 
alcohol consumption. In 2000, he was awarded a Harry Dozor visiting

[[Page 48311]]

professorship at the Ben Gurion University of the Negev, Beersheba, 
Israel. In 2001 and again in 2004, he was awarded invited 
professorships at the University of Strasbourg and University of 
Bordeaux in France. Together with his colleague, Dr. Pierre 
Morm[egrave]de and others, he has helped to organize and deliver 15 1-2 
week workshops on neural and behavioral genetics in France, the USA, 
Brazil, Russia, and Sweden. He and Dr. Morm[egrave]de co-edited two 
volumes of a book on neuro and behavioral genetics. Dr. Jones has 
published more than 130 papers in peer-reviewed journals. In 2013, Dr. 
Jones was invited to help develop research infrastructure to study the 
effects of mercury and pesticide exposure on neurocognitive development 
in Ecuador. In 2014, he was awarded two grants from the National 
Institutes of Health. One is focused on the role of genetics in the 
impact of chronic stress on neuroendocrine adaptation and alcohol 
consumption and the other to study the effects of genetics on paraquat 
neurotoxicity. In that year, he was recruited to help found a new 
department in Genetics, Genomics, and Informatics in the College of 
Medicine at UTHSC. He has served on several NIH and NSF review panels. 
He is on the editorial board of Frontiers in Genetics and Pharmacology, 
Biochemistry and Behavior and is Editor-in-Chief, Nutritional 
Neuroscience. His current research interests include: (1) The 
toxicogenetics of paraquat and other pesticides; (2) the impact of 
chronic stress on neurobehavioral adaptation, including alcohol 
consumption; (3) the role of iron status on accumulation of heavy 
metals; and (4) iron status and the exposure in pregnant women and in 
early childhood development.

9. Paul D. Juarez, Ph.D.

    i. Expertise: Development of methodologies for creating and 
analyzing data on the effects of the natural, built, social, and policy 
environments on health disparities.
    ii. Education: Ph.D., Public Policy and Social Research, Brandeis 
University, Waltham; MEd Psychology, Western Washington University; BA, 
Western Washington University.
    iii. Professional Experience: Dr. Paul D. Juarez is Professor, 
Preventive Medicine and founding co-director of the Research Center on 
Health Disparities, Equity, and the Exposome at the University of 
Tennessee Health Science Center. He received his Ph.D. in social policy 
from the Heller School, Brandeis University in 1983. Dr. Juarez 
currently is serving appointments on the Federal Advisory Committee on 
Minority Health for the US Department of Health and Human Services 
(2014-2018) and the Community-Level Health Promotion Study Section, 
Center for Scientific Review of the NIH (2013-2016). Dr. Juarez 
previously served as the Vice Chair, Division of Community Health, 
Family & Community Medicine, Meharry Medical College. While at Meharry, 
Dr. Juarez was PI for the Meharry Health Disparities Research Center of 
Excellence and directed its community engagement core. As PI, Dr. 
Juarez led Center activities in developing a systems approach to health 
disparities research. In 2011, Dr. Juarez received a grant from the EPA 
to increase our understanding of the environmental context of health 
disparities. In pursuit of this effort, he led efforts to apply an 
exposome framework that considers the cumulative effects of 
environmental exposures on human health and development at critical 
life stages and from conception to death. He has been at the forefront 
nationally in developing a methodology for creating and analyzing data 
on the effects of the natural, built, social, and policy environments 
on health disparities. To achieve this, he has established a 
transdisciplinary team of investigators to conduct focused studies of 
the environmental effects on population level health disparities that 
apply mathematical, spatial-temporal, statistical and computational 
methods, models and analytics. His recent work has focused on analyzing 
the effects of the exposome on black white disparities in pre-term 
births and lung cancer mortality.

10. Rebecca D. Klaper, Ph.D.

    i. Expertise: Ecological toxicology, chemical environment fate and 
effects, examining technologies (including genomics and green chemistry 
designs) to minimize environmental impacts from chemical contamination.
    ii. Education: BS, Honors Biology, University of Illinois; MS, 
Entomology, University of Georgia; Ph.D., Ecology, University of 
Georgia.
    iii. Professional Experience: Dr. Rebecca D. Klaper is a Professor 
at the School of Freshwater Sciences, University of Wisconsin-Milwaukee 
and the Director of the Great Lakes Genomics Center. Dr. Klaper 
received her MS in Entomology in 1995 and her Ph.D. in Ecology in 2000 
from the Institute of Ecology University of Georgia examining the 
impacts of chemicals on the population dynamics of insects. Dr. Klaper 
currently studies the potential impact of emerging contaminants, such 
as nanoparticles, pharmaceuticals, personal care products and 
pesticides on aquatic life and how we may design these chemicals to be 
sustainable and have the least environmental impact. She published some 
of the first studies on the impacts of nanomaterials on aquatic 
organisms, describing differences in toxicity among nanomaterials, 
discussing the possible impacts of surfactants on nanomaterial 
toxicology. Dr. Klaper is now one of the lead PI's for the Center for 
Sustainable Nanotechnology, a distributed Center of eight universities 
to evaluate the mechanisms by which nanomaterials may cause toxicity 
and investigate the potential for principles to use in the design 
process of these chemicals. Dr. Klaper received a AAAS-Science and 
Technology Policy Fellowship where she worked in the National Center 
for Environmental Assessment at the US Environmental Protection Agency 
evaluating the potential use of genomic technologies in risk 
assessment. She currently serves on the Board of Scientific Counselors 
for the US Environmental Protection Agency's Chemical Safety for 
Sustainability/Human Health Risk Assessment Subcommittee. She has 
served as a technical expert to the Alliance for the Great Lakes and 
the International Joint Commission regarding the potential impacts of 
pharmaceuticals, personal care products and other emerging contaminants 
on the Great Lakes. She has also served as an invited scientific expert 
to both the US National Nanotechnology Initiative and the International 
Organization for Economic Cooperation and Development panel on 
nanotechnology where she has testified on the potential impact of 
nanoparticles on the environment and the utility of current testing 
strategies. She served on the National Academy of Sciences Panel to 
Develop a Research Strategy for Environmental, Health, and Safety 
Aspects of Engineered Nanomaterials. She is also on the editorial board 
of the SETAC journal Environmental Toxicology and Chemistry as well as 
the ACS journal Chemical Research in Toxicology. Her current research 
focuses on (1) determining the presence of contaminants in freshwater 
systems; (2) the impacts of low level chronic exposures of these 
chemicals to fish and invertebrates in freshwater systems; (3) 
evaluating the ability of contaminant removal technologies to remove 
biological impacts of chemicals; (4) methods to quickly assess the 
potential impacts of a chemical, including genomic technologies; and 
(5) alternative options for minimizing the impacts of emerging 
contaminants

[[Page 48312]]

including chemical redesign and Green Chemistry, altering use and 
distribution, and evaluating prescription levels for pharmaceuticals. 
Dr. Klaper's goal is to conduct basic and applied research to inform 
policy decisions involving freshwater resources.

11. Polly A. Newcomb, Ph.D.

    i. Expertise: Evaluating environmental exposures, such as metals, 
alcohol, tobacco, and medications, and lifestyle or physical factors, 
such as physical activity, body mass, genetics, and tumor 
characteristics.
    ii. Education: Ph.D., University of Washington, Seattle, 
Epidemiology; MPH, Epidemiology, University of Washington; BS, 
Molecular Biology, The Evergreen State College.
    iii. Professional Experience: Dr. Polly Newcomb is Head of the 
Cancer Prevention Program of the Public Health Sciences Division at the 
Fred Hutchinson Cancer Research Center (Fred Hutch), a Professor in the 
Department of Epidemiology at the University of Washington's School of 
Public Health, and a Senior Scientist at the University of Wisconsin 
Comprehensive Cancer Center. She received her doctorate in Epidemiology 
at the University of Washington in 1986 and completed her Post-doctoral 
Fellowship in the Department of Human Oncology at the University of 
Wisconsin in 1987. She has more than 25 years of extramurally funded 
research on cancer genetics, etiology, screening, and survival, 
demonstrating her broad expertise in the field. Her current research in 
relation to health and cancer includes environmental exposures such as 
metals, alcohol, tobacco, and medications; lifestyle factors, such as 
physical activity and body mass; as well as genetics and tumor 
characteristics. Her research has been funded by nearly a score of 
foundation and NIH-grants for these studies of colorectal neoplasia, 
breast and other cancers, and their precursors. She also participates 
in several international consortia. Dr. Newcomb has over 360 peer-
reviewed publications, has served as a mentor for over 40 pre-doctoral, 
post-doctoral, and junior investigators and is on the Executive 
Committees of four University of Washington/Fred Hutch T32/R25 training 
programs. She is active in training new researchers through a National 
Cancer Institute ``Established Investigator'' award focused on 
colorectal cancer survival. She has served as a member of numerous NIH 
Study Sections, a consultant to national and international 
organizations, and is an Editor/Associate Editor for top tier journals 
such as American Journal of Epidemiology and Cancer, Epidemiology, and 
Biomarkers & Prevention. She has recently been awarded mentoring awards 
from the University of Washington and the Fred Hutchinson Cancer 
Research Center, and is a Fulbright Scholar (2015). She is also the 
President of the American Society for Preventive Oncology.

12. Melissa Perry, ScD, MHS

    i. Expertise: Epidemiologic research in public health.
    ii. Education: BA, Psychology, University of Vermont; MHS, Public 
Health, The Johns Hopkins University School of Hygiene and Public 
Health; ScD, Public Health, The Johns Hopkins University School of 
Hygiene and Public Health.
    iii. Professional Experience: Professor Melissa Perry is the 
elected President of the American College of Epidemiology. Dr. Melissa 
Perry received Master of Health Science and Doctor of Science degrees 
from the Johns Hopkins School of Hygiene and Public Health. She has 
spent more than two decades conducting epidemiologic research and 
educating over 50 graduate students in public health. Prior to coming 
to George Washington University in 2010, Dr. Perry spent 13 years on 
the Harvard School of Public Health's Department of Environmental 
Health faculty. She is currently Chair on the Board of Scientific 
Counselors for the National Center for Environmental Health/Agency for 
Toxic Substances and Disease Registry (NCEH/ATSDR) of the Centers for 
Disease Control and Prevention (CDC). She is also President of the 
American College of Epidemiology. She is an associate editor of the 
Journal Reproductive Toxicology, and she serves as a standing member of 
the National Institute for Occupational Safety and Health research 
grant study section. In 2014, Dr. Perry was elected to the prestigious 
international Collegium Ramazzini in recognition of her contributions 
to advancing occupational and environmental health and her professional 
integrity. From 2009-2011, she was a member of the CDC's Scientific 
Understanding Work Group, National Conversation on Public Health and 
Chemical Exposures, Centers for Disease Control and Prevention. From 
2003-2007, she was a co-investigator with the Tropical Pesticides 
Research Institute of Arusha, Tanzania, and the University of Cape 
Town, South Africa. Her laboratory at the Milken Institute School of 
Public Health focuses on reproductive epidemiology and hormone 
disruptors, and her group has developed new techniques for high-volume 
identification of chromosomal abnormalities in sperm cells. Her 
research group was the first to use semi-automated imaging methods to 
show how pesticides are associated with sperm abnormalities. In 
addition to numerous book chapters and published abstracts, she has 
over 110 peer-reviewed publications in areas including DNA damage 
linked to pesticides and other chemical exposures, managing hazardous 
substances in the workplace, and occupational issues related to 
agricultural, meat-packing, and construction work. Current research on 
pesticides, biomarkers and hormonal effects in her laboratory focuses 
on identifying the mutagenic and hormonal effects of herbicide and 
insecticide exposure in vivo. Her interests focus on pre-disease 
exposure markers signaled by early mutational damage or hormone 
disruption, across the spectrum of pesticide exposure levels. She has 
been the principal investigator on research grants from the National 
Cancer Institute, the National Institute of Environmental Health 
Sciences, and the National Institute for Occupational Safety and 
Health.

13. Patricia V. Pietrantonio, Ph.D., MS

    i. Expertise: Applied insect toxicology, insect endocrinology, and 
insect biochemistry and physiology.
    ii. Education: Ph.D., Entomology, University of California; MS, 
Entomology, Insect Toxicology track, University of California; BS 
Agronomy, Plant Breeding Track, University of Buenos Aires.
    iii. Professional Experience: Dr. Patricia Pietrantonio is a 
tenured Professor and AgriLife Research Fellow in the Department of 
Entomology at Texas A&M University in College Station, TX. She is an 
associate member of the interdisciplinary programs in Toxicology and a 
member of the Faculty of Neuroscience at the same university. She 
received her BS in Agronomy from the University of Buenos Aires in 
Argentina, after which she was a permanent technical staff member at 
INTA (National Institute of Agriculture and Cattle Technology) in 
Castelar, Buenos Aires (1982-1987). She obtained both her MS (1990) and 
Ph.D. (1995) in Entomology from the University of California at 
Riverside (both under Prof. Sarjeet S. Gill), with emphasis in insect 
toxicology, biochemistry, and physiology. As a Ph.D. student, she 
received the Henry Comstock Award from the Entomological Society of 
America (ESA) for outstanding graduate student achievement. Since 1996, 
she has advanced through the ranks at Texas A&M University, receiving 
the title of

[[Page 48313]]

``AgriLife Research Fellow'' for Outstanding Research Leadership and 
Grantsmanship in 2006. She has received funding from the NIH-NIAID 
(RO1), NIFA-AFRI, EPA Section 6 and the NSF-IOS, as well as from the 
Texas Department of Agriculture and USDA-Southern Region IPM program. 
She has served three times as a member on national proposal review 
panels for USDA-NIFA Insects and Nematodes (organismal and sub-
organismal panels) and twice for NSF-IOS panels. She reviews research 
proposals for European Organizations such as the FWO (Belgium), the ANR 
(French Natl. Agency), BBSRC from the UK, the DFG (German Research 
Foundation), and national universities. She has served 19 years at 
Texas A&M University conducting entomological research ranging from 
applied insect toxicology to basic aspects insect endocrinology and 
insect biochemistry and physiology (G protein-coupled receptors: GPCRs) 
focusing on target validation. In applied toxicology her laboratory 
elucidated mechanisms of insecticide resistance to pyrethroids, 
neonicotinoids, and organophosphates in various pests such as 
mosquitoes, cotton bollworm (H. zea), boll weevil, and whiteflies. Some 
of this work was in collaboration with Extension Entomologists. She has 
conducted international research on insecticide resistance in Cyprus 
funded by the Cyprus Research Promotion Foundation. She has served as 
major professor of 7 Ph.D. students and 4 masters students in her 
laboratory and served as committee member for 11 graduate students (all 
completed). She has served as co-major professor or committee member 
for students enrolled in Universities in Mexico and Europe (UK Leuven, 
Belgium). Scholarly accomplishments include 49 published peer-reviewed 
journal articles, 7 book chapters, and 18 papers in conference 
proceedings, as well as published abstracts of 75 invited presentations 
(21 international) and 116 volunteered presentations. She teaches 
yearly Graduate Courses in Insect Toxicology (ENTO619) and Insect 
Physiology (ENTO615). She has served as Subject Editor for 
``Environmental Entomology,'' for which she received an Outstanding 
Service Award from the ESA. She is currently an associate editorial 
member in the Archives of Insect Biochemistry and Physiology and member 
of the Editorial board of Open Access Insect Physiology (Ed. Guy 
Smagghe). Other honors include the Paul A. Dahm Memorial Lecture in 
Insect Toxicology (Iowa State University) and the 2013 College of 
Agriculture and Life Sciences Dean's Outstanding Achievement Award for 
Faculty Mentoring. She was appointed to the University (TAMU) ADVANCE-
NSF funded project as mentor for minority women. Current research 
funded by the NSF-IOS focuses on insect neurobiology and 
neuroendocrinology, and research funded by Cotton Incorporated focuses 
on Bt toxin and other receptors in the cotton bollworm, H. zea. Other 
projects focus on target validation in ticks. Dr. Pietrantonio is also 
a member of the tick genome Ix. scapularis expert group.

14. Kenneth Ramos, MD, Ph.D., PharmB

    i. Expertise: Genomics and computational biology, molecular 
medicine, environmental health, and toxicology.
    ii. Education: BS, Pharmaceutical Sciences and Chemistry, 
University of Puerto Rico, Ph.D., Biochemical Pharmacology, The 
University of Texas; MD, University of Louisville Health Sciences 
Center.
    iii. Professional Experience: Kenneth Ramos, MD, Ph.D., PharmB, 
works across numerous organizational units at the University of Arizona 
(UA) to develop precision-health strategies and approaches to health 
outcomes and health-care delivery. He provides senior leadership in the 
development of personal diagnostics and therapeutics for complex 
diseases, including cancer, cardiopulmonary disorders, and diabetes. 
Dr. Ramos also is a professor of medicine at the UA College of 
Medicine-Tucson in the Department of Medicine, Division of Pulmonary, 
Sleep, and Critical Care Medicine, where he directs a highly 
competitive and innovative research program in translational and 
clinical genetics and genomics. Dr. Ramos' research integrates 
approaches ranging from molecular genetics to population-based studies 
to understand the genomic basis of human disease. He is regarded as a 
leading expert in the study of gene-environment interactions and 
directs a competitive research program in translational and clinical 
genomics with a focus on genetic and epigenetic determinants of 
toxicity and disease, computational biology and molecular signaling. 
Dr. Ramos has mentored over 100 doctoral, medical, veterinary medicine, 
undergraduate and high school students, many of whom have gone on to 
successful careers in academia, medicine, government and industry. He 
is committed to initiatives that attract and retain minorities in 
science and medicine. Dr. Ramos served as SOT President from 2008-2009, 
and is a current member of the Continuing Medical Education Task Force, 
Hispanic Organization of Toxicologists Specialty Interest Group, and 
the Molecular and Systems Biology Specialty Section. He has been a 
member of SOT since 1982.

15. Gary S. Sayler, Ph.D.

    i. Expertise: Microbial biodegradation, molecular microbiology, 
bioluminescence sensing and ecotoxicology.
    ii. Education: Ph.D., Bacteriology and Biochemistry, University of 
Idaho; BS, Bacteriology, North Dakota State University; AA, Liberal 
Arts, Bismarck Junior College.
    iii. Professional Experience: Dr. Sayler is Distinguished 
University Professor, and Alvin and Sally Beaman Endowed Professor of 
Microbiology and Ecology and Evolutionary Biology at The University of 
Tennessee. Dr. Sayler received his Ph.D. in Bacteriology and 
Biochemistry, University of Idaho, 1974; BS, Bacteriology, North Dakota 
State University, 1971; AA, Bismarck Junior College, Liberal Arts, 
1969. He was Postdoctoral researcher in Marine Microbiology at the 
University of Maryland (1974-1975). He is the founding Director, Center 
for Environmental Biotechnology at the University of Tennessee (1986-
present) and was the first Director of the UT-ORNL Joint Institute for 
Biological Sciences (2006-2014). As Director for the Waste Management 
Research and Education Institute Tennessee Center of Excellence (1991-
2005) he conducted a consolidation and reorganization to create the 
Institute for a Secure and Sustainable Environment serving as interim 
director (2005-2006). Specializing in microbial biodegradation, 
molecular microbiology, bioluminescence sensing and ecotoxicology, he 
has directed the research of over 100 Ph.D. and MS students and 
postdocs during his 40 year career, with approximately 400 peer 
reviewed publications, 16 patents, and over 500 lectures and seminars 
worldwide. He serves on the Sciences Advisory Board for the US Defense 
Department, Strategic Environmental Research Defense Program (2011-
present); and was a member of the US Department of Energy, Biological 
and Environmental Research Advisory Committee (2008-2013). He was an 
Executive member and Chair of the Board of Scientific Counselors for 
the EPA Office of Research and Development (2002-2010) and served on 
the EPA's Science Advisory Board drinking water committee (2002-2009), 
the Water Environment Research Foundation Research Council (1995-2001) 
and was Peer Review Chair for the EPA Exploratory Biology Program

[[Page 48314]]

(1990-1993). He has served on National Academy/NRC Committees 
evaluating the US EPA Laboratory Enterprise (2013-14), DOE NRSB-
Environmental Management Roadmap (2007-2008) Stand-Off Explosives 
Detection (2003) and DOE Site Decontamination and Decommissioning 
(2002). He is Co-founder China-US Joint Research Center For Ecosystem 
and Environmental Change, Beijing, (2006-present) and US State 
Department Eco partnership (2010-present) and has held honorary 
Professorships at China Agricultural University, Beijing (2012), 
Northeast Normal University, Changchun (2012), East China University of 
Science and Technology, Shanghai (2008-2011), Institute for Water 
Research Distinguished Researcher, Xi'an (2008); and Adjunct 
Professorship, Gwanju Institute of Science and Technology, Korea (2005-
2010). Dr. Sayler is an Associate Editor of Environmental Science and 
Technology and is an active member in ACS, AAAS, ASM and SETAC. Elected 
to AAAS Fellowship in 2012. He received the DOW Foundation Support for 
Public Health Environmental Research and Education (SPHERE) Award 
(1998-2000); and was elected to the Fellow American Academy for 
Microbiology (1995-present). He received the Distinguished Alumni 
Award, University of Idaho and the UT Senior Researcher Award from the 
College of Arts and Sciences (1995) and received the Procter and Gamble 
Prize, American Society for Microbiology (1994). He was designated 
Chancellor's Research Scholar, UTK (1988), and received the NIH 
Research Career Development Award (NIEHS), (1980-1985).

16. Joseph Shaw, Ph.D.

    i. Expertise: Discovery of molecular toxicological and disease 
pathways resulting from complex environmental exposures including 
techniques in new high-throughput molecular techniques and evolutionary 
theory, statistical analysis, and bioinformatics.
    ii. Education: Ph.D., University of Kentucky; BS, Virginia 
Polytechnic Institute and State University.
    iii. Professional Experience: Dr. Joseph R. Shaw is an Associate 
Professor in the School of Public and Environmental Affairs at Indiana 
University and holds adjunct appointments in their School of Public 
Health and Center for Genomics and Bioinformatics. He also holds a 
partial appointment as a Senior Lecturer of Environmental Genomics in 
the School of Biosciences at the University of Birmingham, UK. Dr. Shaw 
earned his doctoral degree in environmental toxicology from the 
Graduate Center for Toxicology at the University of Kentucky in 2001. 
He then moved to Dartmouth College where he received an NIEHS post-
doctoral fellowship to apply emerging Omics technologies to 
characterize mechanisms of toxicant actions. He joined the faculty of 
the School of Public and Environmental Affairs at Indiana University, 
Bloomington in 2007. Dr. Shaw was named an Outstanding New 
Environmental Scientist (ONES) by the NIEHS in 2010, and recognized as 
an exceptional talent in the environmental sciences by the Royal 
Society, UK in 2013 for his work investigating toxicant exposure, 
genome structure, and toxic effects on individuals and populations. 
Contributing to these efforts he is a founding member of the Daphnia 
and Fundulus Genomics Consortia where he helps lead over 600 scientists 
around the world working to develop new models for environmental 
genomics. He also helped establish the Consortium for Environmental 
Omics and Toxicology that seeks to apply twenty-first century 
technologies to predictive toxicology. Dr. Shaw has trained over 150 
students in environmental genomics through the Mount Desert Island Bio 
Lab Workshop in environmental genomics that he co-developed in 2011. 
The workshop is now held annually in the US and UK. Dr. Shaw's research 
program has received over $6.4M in research funding from NIH, NSF, and 
DOD since 2002, producing over 38 publications in the area of 
environmental genomics and toxicology. He has served on the editorial 
board and in 2013, was promoted to editor for the journal 
``Environmental Toxicology and Chemistry.'' His research group seeks to 
discover critical, specific, and causative molecular toxicological and 
disease pathways resulting from complex environmental exposures. His 
work embraces new high-throughput molecular techniques and couples 
these with evolutionary theory, statistical analysis, and 
bioinformatics to integrate toxic-response across levels of biological 
organization. Current research in his laboratory focuses on (i) 
associating variation in genome structure with disease and toxicant 
response within and between populations; (ii) identifying the 
mechanisms of actions of chemical stress, especially metals, and (iii) 
elucidating the genetic and epigenetic underpinnings of mutations and 
establishing their role in evolved tolerance.

17. Sonya K. Sobrian, Ph.D.

    i. Expertise: Behavioral, immunological and neurotoxicological 
consequences of prenatal and neonatal drug administration and drug and 
environmental stress.
    ii. Education: Ph.D. Physiological Psychology, from Carleton 
University; BA and MA (Experimental) in Psychology from St. John's 
University; MA equivalent in Pharmacology from Ottawa University.
    iii. Professional Experience: Dr. Sonya K. Sobrian is an Associate 
Professor of Pharmacology at the Howard University College of Medicine, 
Director of the Developmental Neurobehavioral Pharmacology Laboratory, 
and Immediate Past Chair of the University's IACUC. Dr. Sobrian 
received her doctorate in Physiological Psychology from Carleton 
University, Ottawa Canada, and served a postdoctoral fellowship at 
Princeton University in Developmental Neurobiology; she also added 
pharmacology and immunology to her graduate (MA, Neuropharmacology: 
Ottawa University) and post graduate (Fulbright Fellow: Immunology 
Research Center, Belgrade, Yugoslavia) training. During her tenure at 
the College of Medicine, Dr. Sobrian successfully mentored medical, 
graduate, and undergraduate students. She has served as President of 
the Neurobehavioral Teratology Society, is currently on the Editorial 
Advisory Board of the journal, ``Neurotoxicology and Teratology'', and 
is Guest Editor of a special issue of the journal on ``Developmental 
Cannabinoid Exposure: New Perspectives on Mechanisms, Outcomes, and 
Implications for Public Health.'' Dr. Sobrian is currently on the Board 
of Scientific Counselors for the Department of Health & Human Services 
National Toxicology Program. She also served as a member of the 
Scientific Advisory Panel for the US EPA Office of Chemical Safety and 
Pollution Prevention, and previously served on the EPA Toxic Substance 
Control Act Advisory Committee. As a visiting scientist at the National 
Center for Toxicological Research, Dr. Sobrian was instrumental in 
establishing a prenatal model of cocaine toxicity. She served on the 
ILSI Risk Science Institute's Expert Panel on the evaluation and 
interpretation of neurodevelopmental endpoints for human risk. Dr. 
Sobrian served as Director of the Behavioral Neuroscience Program at 
the National Science Foundation, where she directed and managed funding 
of research on the neural mechanisms underlying behavior and learning. 
In addition, she has served as Chair of the Board of Trustees of AAALAC 
International, as well as Chair of the Board of Directors of the 
National Capital Area Chapter of the Fulbright Association. During her 
tenure as an

[[Page 48315]]

AAAS Congressional Science and Technology Fellow, her scientific 
expertise was utilized to inform public policy on Fetal Alcohol 
Syndrome, aging, and NIH research funding. The major focus of Dr. 
Sobrian's research involves the behavioral, immunological, and 
neurotoxicological consequences of prenatal and neonatal drug 
administration and drug and environmental stress-induced alterations in 
behavioral and immunological development. She has a longstanding 
interest in sex differences, and her lab was the first to show that 
prenatal environmental and psychological stress differentially altered 
immune parameters in rat male and female offspring, research that she 
continued as a Fulbright Scholar at the Immunological Research 
Institute in Belgrade, Yugoslavia. Her current research involves the 
life-span consequences of prenatal exposure to cocaine and nicotine, 
alone and in combination, with an emphasis on drug addiction in the 
aging organism. In developing animal models for neuropsychiatric 
diseases, Dr. Sobrian is currently exploring the role of prenatal 
environmental noise stress [PENS] in the etiology of autism and 
depression. For her work in establishing an environmentally-mediated 
neurodevelopmental animal model of depression, Dr. Sobrian was 
designated a L. Vernon Maddox NARSAD investigator.

18. Kristina Thayer, Ph.D.

    i. Expertise: Understanding the role of environmental exposures in 
diabetes and obesity, evaluating the predictive utility of high 
throughput screening data, and methods of exposure assessment.
    ii. Education: BS, Psychology, Pennsylvania State University; 
Ph.D., Biological Sciences, University of Missouri.
    iii. Professional Experience: Kristina Thayer, Ph.D. is Deputy 
Director of Analysis at the National Toxicology Program (NTP) and 
Director of the NTP Office of Health Assessment and Translation (OHAT) 
at the National Institute for Environmental Health Sciences (NIEHS) 
located on the campus of the National Institute for Environmental 
Health Sciences (NIEHS). OHAT conducts evaluations to assess the 
evidence that environmental chemicals, physical substances, or mixtures 
(collectively referred to as ``substances'') may cause adverse health 
effects and provides opinions on whether these substances may be of 
concern given what is known about current human exposure levels. As 
Deputy Director of Analysis, she oversees OHAT and the NTP Office of 
the Report on Carcinogens. Before becoming director of OHAT, she held 
positions in the NTP Office of Liaison, Policy, and Review, the NIEHS 
Office of Risk Assessment Research and the NTP Center for the 
Evaluation of Risks to Human Reproduction (CERHR). Prior to joining the 
NTP/NIEHS, she was a senior scientist at the World Wildlife Fund and 
then at the Environmental Working Group. In addition to overseeing the 
development of OHAT and ORoC monographs, she has research interests in 
the areas of understanding the role of environmental exposures in 
diabetes and obesity, evaluating the predictive utility of high 
throughput screening data, and methods of exposure assessment. She is 
considered an expert on the application of systematic review methods to 
environmental health topics.

    Authority:  7 U.S.C. 136 et. seq.; 21 U.S.C. 301 et seq.

    Dated: August 5, 2015.
David Dix,
Director, Office of Science Coordination and Policy.
[FR Doc. 2015-19828 Filed 8-11-15; 8:45 am]
 BILLING CODE 6560-50-P